BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21276610)

  • 1. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
    Anglesio MS; Carey MS; Köbel M; Mackay H; Huntsman DG;
    Gynecol Oncol; 2011 May; 121(2):407-15. PubMed ID: 21276610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives.
    Yoshida S; Furukawa N; Haruta S; Tanase Y; Kanayama S; Noguchi T; Sakata M; Yamada Y; Oi H; Kobayashi H
    Cancer Treat Rev; 2009 Nov; 35(7):608-15. PubMed ID: 19665848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
    Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
    Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative assessment of clear cell carcinoma of the ovary.
    Stewart CJ; Brennan BA; Hammond IG; Leung YC; McCartney AJ; Ruba S
    Int J Gynecol Pathol; 2008 Oct; 27(4):475-82. PubMed ID: 18753976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.
    Itamochi H; Kigawa J; Terakawa N
    Cancer Sci; 2008 Apr; 99(4):653-8. PubMed ID: 18377417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.
    Sugiyama T; Kamura T; Kigawa J; Terakawa N; Kikuchi Y; Kita T; Suzuki M; Sato I; Taguchi K
    Cancer; 2000 Jun; 88(11):2584-9. PubMed ID: 10861437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [III. Ovarian cancer 1. Ovarian clear cell carcinoma].
    Tsuda H; Aoki D
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):198-201. PubMed ID: 22545287
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy.
    Matsuura M; Suzuki T; Saito T
    Cancer Sci; 2010 Aug; 101(8):1828-33. PubMed ID: 20545695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
    Sangoi AR; Soslow RA; Teng NN; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
    Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
    Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis.
    Lee YY; Kim TJ; Kim MJ; Kim HJ; Song T; Kim MK; Choi CH; Lee JW; Bae DS; Kim BG
    Gynecol Oncol; 2011 Sep; 122(3):541-7. PubMed ID: 21640372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian clear cell carcinoma with choriocarcinomatous differentiation: report of a rare and aggressive tumor.
    Hu YJ; Ip PP; Chan KK; Tam KF; Ngan HY
    Int J Gynecol Pathol; 2010 Nov; 29(6):539-45. PubMed ID: 20881859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clear cell carcinoma of the ovary simulating a yolk sac tumor].
    Bahri I; Boudawara T; Khabir A; Beyrouti MI; Frikha M; Jlidi R
    Ann Pathol; 2003 Apr; 23(2):165-8. PubMed ID: 12843973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
    Chew S; Tham KF; Ratnam SS
    Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman.
    Yang YH; Chen RJ; Lin MC; Cheng SP; Chang TC
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):97-100. PubMed ID: 20466303
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of prognostic factors of epithelial ovarian carcinoma].
    Shao SL; Liu XS
    Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):132-6. PubMed ID: 20420785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
    Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
    Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
    Schwartz DR; Kardia SL; Shedden KA; Kuick R; Michailidis G; Taylor JM; Misek DE; Wu R; Zhai Y; Darrah DM; Reed H; Ellenson LH; Giordano TJ; Fearon ER; Hanash SM; Cho KR
    Cancer Res; 2002 Aug; 62(16):4722-9. PubMed ID: 12183431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.